Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

by Impact JournalsExpression of lncRNA MVIH in CC tumor as compared to marginal non-tumor tissues. Credit:Genes & Cancer(2022). DOI: 10.18632/genesandcancer.224A new research paper was

Updated on: December 17,2023 10

Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

by Impact JournalsExpression of lncRNA MVIH in CC tumor as compared to marginal non-tumor tissues. Credit:Genes & Cancer(2022). DOI: 10.18632/genesandcancer.224A new research paper was

Updated on:December 17,2023 10

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Updated on: December 17,2023 10

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Updated on:December 17,2023 10

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on: December 17,2023 10

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on:December 17,2023 10

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Updated on: December 17,2023 12

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Updated on:December 17,2023 12

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w

Updated on: December 17,2023 10

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w

Updated on:December 17,2023 10

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;

Updated on: December 17,2023 10

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;

Updated on:December 17,2023 10

PAD4 inhibition in neutrophils halts cancer progression and metastasis

byThe Wistar InstituteCancer Cell Dividing. Credit: The Wistar InstituteResearchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therap

Updated on: December 17,2023 10

PAD4 inhibition in neutrophils halts cancer progression and metastasis

byThe Wistar InstituteCancer Cell Dividing. Credit: The Wistar InstituteResearchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therap

Updated on:December 17,2023 10

PSMA PET scanning can improve decision making for prostate cancer treatment

bySociety of Nuclear MedicineHeat map of prostate bed PSMA PET recurrences distribution in the miTr N0 Mo cohort (n=127 patients) mapped on a template patient’s anatomy (the green contour repres

Updated on: December 17,2023 10

PSMA PET scanning can improve decision making for prostate cancer treatment

bySociety of Nuclear MedicineHeat map of prostate bed PSMA PET recurrences distribution in the miTr N0 Mo cohort (n=127 patients) mapped on a template patient’s anatomy (the green contour repres

Updated on:December 17,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023 10

Analysis of radiotherapy and locoregional recurrence in RxPONDER patients

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainAn analysis of data on the use of radiation therapy in a large clinical trial of patients with HR+, HER2- breast cancer who had one to

Updated on: December 17,2023 10

Analysis of radiotherapy and locoregional recurrence in RxPONDER patients

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainAn analysis of data on the use of radiation therapy in a large clinical trial of patients with HR+, HER2- breast cancer who had one to

Updated on:December 17,2023 10

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023 10

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023 10

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom

Updated on: December 17,2023 10

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom

Updated on:December 17,2023 10